home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login » Fund III Investor Login »

news

Jun5Earlens Closes $118m in Mixed Debt and Equity Round »


Earlens said today it closed a total of $118 million in funding, with $73 million coming from an offering of Series C preferred stock and $45 from a structured debt facility with...

Read More »

May23Viveve Secures $30 million Debt Financing with CRG »


SUNNYVALE, CA -- 05/23/17 -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's health, today announced that it has entered into a senior credit...

Read More »

May15Cardiome Announces Amendment to Term Loan Agreement With CRG-Managed Funds »


Vancouver, Canada, May 15, 2017 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") today announced that it has amended its term loan agreement with CRG-managed funds (the "Amended...

Read More »

May12Maxigesic on Track to Access the Large United States Painkiller Market »


AFT Pharmaceuticals has been officially notified that the US Food and Drug Administration (FDA) has accepted its application to register its painkiller Maxigesictablets in the United States.   AFT Board...

Read More »

May10Intrinsic Therapeutics Announces the Completion of a $49m Financing »


Funding Supports FDA Approval Process and Global Market Access   BOSTON, May 10, 2017 /PRNewswire/ -- Intrinsic Therapeutics, Inc. a medical device company that has developed a product to improve...

Read More »

May3Outset Medical Announces $76.5 Million in Funding for Innovative Dialysis Technology »


-- Financing to Expand U.S. Commercial Introduction and Manufacturing --   SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the $13 billion global...

Read More »

Apr13ViewRay Announces $15.0 Million Capacity Expansion of its Term Loan Agreement »


-- Announces Preliminary Q1 2017 New Orders and Cash Position Reiterates 2017 Financial Guidance --   CLEVELAND, OH April 13, 2017 — ViewRay, Inc. (Nasdaq: VRAY) today announced that it has reached an agreement...

Read More »

Mar23Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock »


SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced...

Read More »

Mar23Valeritas Announces Pricing of $52.5 Million Public Offering of Common Stock »


BRIDGEWATER, N.J., March 23, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) today announced the pricing of its underwritten public offering of 5,250,000 shares of its common stock at a public...

Read More »

Mar13Astute Medical Expands Relationship with bioMérieux, Inc. and Ortho Clinical Diagnostics to Enhance Nephrocheck Test Market Access »


San Diego – March 13, 2017 – Astute Medical, Inc. (“Company”), developer of biomarkers for better healthcare, today announced two agreements aimed at expanding global access to the NephroCheck...

Read More »

Mar9Autonomic Technologies Announces Expanded Indication in Europe (CE mark) for Disabling Migraine with Pulsante® SPG Microstimulator System »


Cluster headache therapy now indicated for pain relief in highly disabled migraine patients   Redwood City, CA (March 9, 2017) Autonomic Technologies, Inc. announced today that it has received an expanded indication ...

Read More »

Mar7Envision Healthcare Enters Definitive Agreement to Acquire Imaging Advantage »


Transaction to Expand Envision’s Radiology Physician Services   Nashville, Tenn. & Greenwood Village, Colo.--(BUSINESS WIRE)--Envision Healthcare Corporation (NYSE: EVHC) has entered into a definitive agreement...

Read More »

Mar6TearLab Announces CE Marking for Next-Generation System »


SAN DIEGO, March 06, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) today announced that its next-generation in-vitro diagnostics testing platform is in conformity with all...

Read More »

Feb27ViewRay Receives FDA 510(k) Clearance for MRIdian Linac »


-- Announces Fourth Quarter and Full Year 2016 Financial Highlights, including Record Revenue and $133.2 million in Backlog --   CLEVELAND, February 27, 2017 — ViewRay, Inc. (Nasdaq: VRAY) announced today that the...

Read More »

Feb23BioDelivery Sciences Secures Debt Financing with CRG »


-- Upfront proceeds extend cash runway into 2nd half of 2018 --   RALEIGH, N.C., Feb. 23, 2017 -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has...

Read More »
Load More